NYSE:KDMN - Kadmon Holdings, Inc.
$2.56
 $0.08
+3.23%
12:00PM EDT
2019-07-22
Kadmon Holdings, Inc., incorporated on September 15, 2010, is an integrated biopharmaceutical company engaged in the discovery, development and commercialization of small molecules and biologics to address disease areas of various unmet medical needs. The Company is developing product candidates in a number of indications within autoimmune and fibrotic disease, oncology and genetic diseases. The Company's product pipeline consists of KD025, Tesevatinib and KD034. The Company's other products include Ribasphere RibaPak, Ribasphere, Qsymia, Tetrabenazine and Valganciclovir.KD025KD025 is an orally available, selective small molecule inhibitor of Rho-associated coiled-coil kinase 2 (ROCK2), a molecular target in multiple autoimmune, fibrotic and neurodegenerative diseases. KD025 is indicated for the treatment of Psoriasis Vulgaris, Idiopathic Pulmonary Fibrosis, and Chronic Graft-Versus-Host Disease. The Company is conducting a Phase II randomized, double-blind, placebo-controlled clinical study to evaluate the safety, tolerability and activity of KD025 for Psoriasis Vulgaris, Idiopathic Pulmonary Fibrosis, and Chronic Graft-Versus-Host Disease.TesevatinibTesevatinib is an oral tyrosine kinase inhibitor (TKI) designed to block key molecular drivers of tumor growth, metastases and drug resistance. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  KDMN     avg for
industry  
  avg for
sector  
42 stocks weight:  8. 79   217. 37   399. 45  
42 stocks rank:  3. 86 K 1. 27 K 716. 99  
# analyst opinions:  4. 00   13. 21   13. 71  
mean recommendation:  1. 30   2. 10   2. 04  

quick ratio:  3. 78   5. 49   1. 88  
current ratio:  3. 89   5. 87   2. 36  

target price low:  2. 50   83. 44   114. 90  
target price avg:  2. 90   106. 20   137. 90  
target price high:  3. 57   132. 30   158. 97  
1-yr high:  4. 31   111. 86   142. 57  
last close:  2. 48   86. 79   125. 44  
50-day avg:  2. 11   86. 68   122. 63  
200-day avg:  2. 41   89. 22   121. 38  
1-yr low:  1. 65   69. 78   100. 51  
volume:  524. 99 K 2. 62 M 3. 43 M
50-day avg volume:  1. 02 M 3. 20 M 4. 16 M
200-day avg volume:  863. 66 K 2. 99 M 4. 75 M

1-day return:  -4. 98 % -1. 30 % -0. 99 %
this week return:  1. 64 % 0. 45 % -0. 20 %
12-wk return:  9. 25 % 0. 94 % 4. 84 %
52-wk return:  -22. 45 % -1. 30 % 10. 55 %

enterprise value (EV):  341. 73 M 45. 10 B 122. 38 B
market cap:  321. 11 M 38. 96 B 108. 40 B
EBITDA:  -89. 23 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  -3. 83   5. 38   11. 93  
enterprise/revenue (EV/R):  331. 46   57. 92   10. 21  
total revenue:  1. 03 M 9. 91 B 39. 98 B
total debt:  53. 93 M 10. 90 B 17. 48 B
debt/equity:  43. 77   57. 18   120. 05  
net income (common):  -32. 26 M 2. 07 B 4. 05 B

shares outstanding:  126. 91 M 538. 09 M 1. 24 B
shares:  70. 63 M 548. 00 M 1. 22 B
shares short:  7. 10 M 10. 98 M 11. 87 M
shares short prior month:  9. 64 M 9. 32 M 12. 05 M
short ratio:  5. 84   5. 60   3. 34  
short % of float:  7. 05 % 6. 48 % 2. 64 %
total cash/share:  0. 77   10. 98   9. 19  
total cash:  99. 36 M 5. 93 B 6. 10 B
free cash flow:  -45. 57 M 2. 92 B 4. 55 B
operating cash flow:  -78. 25 M 3. 80 B 5. 78 B

book value:  0. 63   13. 35   27. 45  
price/book:  3. 91   4. 60   8. 78  
gross profits:  714. 00 K 7. 44 B 36. 13 B
operating margins:  -8795. 34 % -308. 40 % -28. 55 %
EBITDA margins:  0. 00 % 13. 17 % 23. 38 %
profit margins:  0. 00 % 10. 44 % 14. 18 %
gross margins:  64. 40 % 35. 80 % 55. 40 %

1-yr max volatility:  18. 11 % --- ---
1-yr mean volatility:  3. 00 % 1. 66 % 1. 03 %

1-yr EPS:  -0. 30   2. 10   4. 23  
forward EPS:  -0. 66   3. 45   7. 10  
P/E:  -8. 35   1. 90   32. 10  
forward P/E:  -3. 95   6. 46   15. 47  
PE/G:  0. 10   0. 70   -0. 54  
growth:  -84. 30 % 265. 63 % 79. 11 %
earnings high:  -0. 15   0. 89   1. 68  
earnings avg:  -0. 16   0. 70   1. 57  
earnings low:  -0. 17   0. 46   1. 46  
revenue high:  800. 00 K 2. 57 B 11. 07 B
revenue avg:  460. 00 K 2. 51 B 10. 91 B
revenue low:  190. 00 K 2. 45 B 10. 73 B
return on assets:  -43. 26 % -2. 34 % 5. 28 %
return on equity:  -46. 09 % -90. 08 % 133. 53 %
revenue growth:  -84. 30 % 265. 25 % 73. 68 %
revenue/share:  0. 01   12. 72   60. 04  

beta (1yr vs S&P500):  1. 17   1. 27   0. 91  
sharpe (1yr):  -0. 18   0. 16   0. 77  

held % insiders:  0. 43 % 6. 06 % 3. 29 %
held % institutions:  66. 16 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : KDMN
.    101.335 =       101.335 :: --> INITIAL WEIGHT <--
.    - 0.297 =       101.038 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.217 =       224.011 :: P/E factor
.    x 1.783 =       399.303 :: PE/G factor
.    x 1.686 =        673.36 :: beta factor
.    x 0.702 =       472.962 :: sharpe factor
.    x 2.663 =      1259.459 :: current ratio factor
.    x 1.166 =      1468.544 :: quick ratio factor
.    x 1.082 =       1589.31 :: short ratio factor
.    x 3.142 =      4992.965 :: EV/R factor
.    x 1.047 =       5229.18 :: price-to-book factor
.    x 0.644 =      3365.328 :: debt-to-revenue factor
.    x 1.329 =      4471.497 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.121 =      9483.119 :: sector+industry 1-year gains factor
.    x 1.009 =      9572.527 :: industry 12-weeks return factor
.    x 1.308 =     12519.798 :: industry 2-weeks return factor
.    x 1.119 =     14005.484 :: 5-day avg > 200-day avg
.    x 1.876 =     26268.864 :: 5-day avg > 50-day avg
.    x 0.997 =     26193.812 :: "drift" penalty 3 days ago
.    x 0.968 =     25344.873 :: "drift" penalty 5 days ago
.    / 2.081 =     12176.592 :: overall "drift" factor
.    x 0.792 =      9648.644 :: largest single-day jump factor
.    x 0.068 =        656.37 :: low price factor
.     x 0.13 =        85.654 :: notable returns + performance factor
.    x 2.742 =       234.851 :: performance vs s&p500 factor
.                               --> PROJECTIONS <--
.    x 0.436 =       102.301 :: forward EPS factor
.    x 0.795 =         81.32 :: forward P/E factor
.    x 1.185 =        96.341 :: industry recommendation factor
.    x 2.842 =       273.761 :: company recommendation factor
.    x 1.003 =       274.518 :: factor historical industry gain for week 29
.    x 1.111 =       305.105 :: target low factor
.    x 1.137 =       346.958 :: target mean factor
.    x 1.028 =       356.625 :: target high factor
.    x 9.435 =      3364.747 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =         7.616 :: reduced for readability
.    + 1.177 =         8.793 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                      8.793 :: FINAL WEIGHT for NYSE:KDMN


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org